Journal of Medical Economics, Volume 20, Issue 2 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 20, Issue 2 (2017)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Volume 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Modeling

Article
The Load Model: an alternative to QALY
Tim Benson
Pages: 107-113
Published online: 07 Sep 2016
AbstractforThe Load Model: an alternative to QALY | Full Text | References | PDF (775.7 KB)
  • 2684 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Hospitalization expenses of acute ischemic stroke patients with atrial fibrillation relative to those with normal sinus rhythm
Jiming Li & Weiliang Luo
Pages: 114-120
Published online: 08 Sep 2016
AbstractforHospitalization expenses of acute ischemic stroke patients with atrial fibrillation relative to those with normal sinus rhythm | Full Text | References | PDF (797.5 KB)
  • 550 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Marjan Massoudi, Mark Balk, Hongbo Yang, Cat N. Bui, Bhavik J. Pandya, Jenny Guo, Yan Song, Eric Q. Wu, Bruce Brown, Arie Barlev & Scott Flanders
Pages: 121-128
Published online: 16 Sep 2016
AbstractforNumber needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer | Full Text | References | PDF (795.9 KB)
  • 2567 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Pain

Review
A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future
Simone Critchlow, Matthew Hirst, Ron Akehurst, Ceri Phillips, Zoe Philips, Will Sullivan & Will C.N. Dunlop
Pages: 129-139
Published online: 16 Sep 2016
AbstractforA systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future | Full Text | References | PDF (971.8 KB)
  • 2481 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States
Min Huang, Yanyan Lou, James Pellissier, Thomas Burke, Frank Xiaoqing Liu, Ruifeng Xu & Vamsidhar Velcheti
Pages: 140-150
Published online: 03 Oct 2016
AbstractforCost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States | Full Text | References | PDF (1.6 MB)
  • 3262 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Article
Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients
Daniel M. Gilden, Joanna M. Kubisiak, Gerhardt M. Pohl, Daniel E. Ball, David E. Gilden, William J. John, Stewart Wetmore & Katherine B. Winfree
Pages: 151-161
Published online: 14 Sep 2016
AbstractforTreatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients | Full Text | References | PDF (1.8 MB) | Supplemental
  • 1223 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population
Olivier Ethgen, Yuri Sanchez Gonzalez, Grégoire Jeanblanc, Aurore Duguet, Derek Misurski & Timothy Juday
Pages: 162-170
Published online: 21 Sep 2016
AbstractforPublic health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population | Full Text | References | PDF (1.2 MB)
  • 1597 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
Unchalee Permsuwan, Piyameth Dilokthornsakul, Kednapa Thavorn, Surasak Saokaew & Nathorn Chaiyakunapruk
Pages: 171-181
Published online: 29 Sep 2016
AbstractforCost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand | Full Text | References | PDF (1.2 MB)
  • 1484 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Estimates of the direct and indirect cost savings associated with heart disease that could be avoided through dietary change in the United States
John Cawley, Chad Meyerhoefer, Leah G. Gillingham, Penny Kris-Etherton & Peter J. H. Jones
Pages: 182-192
Published online: 11 Oct 2016
AbstractforEstimates of the direct and indirect cost savings associated with heart disease that could be avoided through dietary change in the United States | Full Text | References | PDF (859.1 KB)
  • 915 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer
Emily-Ruth Marriott, Guy van Hazel, Peter Gibbs & Anthony J. Hatswell
Pages: 193-199
Published online: 13 Oct 2016
AbstractforMapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer | Full Text | References | PDF (817.3 KB)
  • 1761 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Report
Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism
Craig I. Coleman, Christopher Baugh, Concetta Crivera, Dejan Milentijevic, Sheng-Wei Wang, Lang Lu & Winnie W. Nelson
Pages: 200-203
Published online: 26 Oct 2016
AbstractforHealthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism | Full Text | References | PDF (366 KB)
  • 853 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Ophthalmology

Article
Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan
Yasuo Yanagi, Aya Fukuda, Victor Barzey & Kenji Adachi
Pages: 204-212
Published online: 25 Oct 2016
AbstractforCost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan | Full Text | References | PDF (1 MB) | Supplemental
  • 1888 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Explore articles